Spectroscopy Department, National Research Centre, 12311 Dokki, Cairo, Egypt.
Med Chem. 2012 Sep;8(5):826-30. doi: 10.2174/157340612802084144.
Two novel groups of hexapeptide inhibitors for NS3 serine protease of the hepatitis C virus (HCV) are designed. The hexapeptide is an amino acid sequence of NS5A/NS5B substrate (Glu-Asp-Val-Val-Cys-Cys). In the first group, the hexapeptide binds to a cellulose monomer at the positions 2, 3 or 6 while in the second group, the hexapeptide binds to a cellulose dimmer at the positions 2, 3, 6, 2', 3' or 6'. Molecular modeling semiemprical PM3 calculations are used to optimize the geometry and calculate the electronic properties of the suggested inhibitors compared to that of natural substrate. Computational results show that the second group has the maximum stability and reactivity indicating that it would be considered as a promising HCV NS3 protease inhibitor.
设计了两种新型六肽抑制剂用于丙型肝炎病毒(HCV)的 NS3 丝氨酸蛋白酶。六肽是 NS5A/NS5B 底物(Glu-Asp-Val-Val-Cys-Cys)的氨基酸序列。在第一组中,六肽结合在纤维素单体的 2、3 或 6 位,而在第二组中,六肽结合在纤维素二聚体的 2、3、6、2'、3'或 6'位。半经验 PM3 分子建模计算用于优化建议抑制剂的几何形状并计算电子性质,与天然底物进行比较。计算结果表明,第二组具有最大的稳定性和反应性,表明它将被认为是一种有前途的 HCV NS3 蛋白酶抑制剂。